2020
DOI: 10.4103/jispcd.jispcd_304_20
|View full text |Cite
|
Sign up to set email alerts
|

Povidone–iodine solution: A potential antiseptic to minimize the risk of COVID-19? A narrative review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 10 publications
(14 citation statements)
references
References 34 publications
0
11
0
3
Order By: Relevance
“…The concentration and duration of PVP-I can be decided based on the mucous and salivary flow of the individual. Since the flow rate of saliva in a hospital-bound semiconscious patient is low and clearance of PVP-I is slower than usual, prolonged exposure of PVP-I is indicated [69] , [70] . It is recommended that, for complete viral eradication, PVP-I products should be used for two weeks at least, or until local authorities control the risk of infectivity.…”
Section: Discussionmentioning
confidence: 99%
“…The concentration and duration of PVP-I can be decided based on the mucous and salivary flow of the individual. Since the flow rate of saliva in a hospital-bound semiconscious patient is low and clearance of PVP-I is slower than usual, prolonged exposure of PVP-I is indicated [69] , [70] . It is recommended that, for complete viral eradication, PVP-I products should be used for two weeks at least, or until local authorities control the risk of infectivity.…”
Section: Discussionmentioning
confidence: 99%
“…31 Castro mediante su investigación en pacientes con PCR positiva al SARS-CoV-2 evidenció una disminución estadísticamente significativa en la disminución de carga viral en el lapso de tres horas, concluyendo ser un protocolo profiláctico adecuado previo a la atención estomatológica. 32…”
Section: Discussionunclassified
“…PVP-I is a proven antiseptic agent with excellent virucidal properties (99.99%) [25] , dilute solutions of PVP-I have historically been used in Asia to treat upper respiratory tract infections [26] . Antiseptic nasal and oral PVP-I solutions are effective in inactivating SARS-CoV-2 at a variety of concentrations after exposure times of 60 seconds [27,28] . Recent evidence has confirmed that mouthwash/gargling with 0.5% povidone-iodine (PVP-I) for 30 seconds can reduce SARS-CoV-2 virus infectivity below detectable levels [6] .…”
Section: Povidone Iodinementioning
confidence: 99%